Cellular lifespan and senescence signaling in embryonic stem cells

Aging Cell

Volumn 3, Issue 6, 2004, Pages 333-343

  Miura, Takumi ^a   Mattson, Mark P ^a,b   Rao, Mahendra S ^a,b  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aging; Akt signaling; Cell cycle; ES cells; p53; Rb; Senescence; Telomerase; Telomere

Indexed keywords

PROTEIN KINASE B; PROTEIN P53; RETINOBLASTOMA PROTEIN; SOMATOMEDIN; TELOMERASE;

ANIMAL CELL; CELL AGING; CELL CULTURE; CELL DIVISION; CELL IMMORTALIZATION; CELL PROLIFERATION; CELL SURVIVAL; DNA DAMAGE; EMBRYONIC STEM CELL; HUMAN; HUMAN CELL; MAMMAL CELL; MITOGENESIS; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; TELOMERE;

CELL AGING; EMBRYO; HUMANS; MODELS, BIOLOGICAL; SIGNAL TRANSDUCTION; STEM CELLS;

EID: 13844257292     PISSN: 14749718     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1474-9728.2004.00134.x     Document Type: Review

References (125)

1. Aladjem MI, Spike BT, Rodewald LW, Hope TJ, Klemm M, Jaenisch R, Wahl GM (1998) ES cells do not activate p53-dependent stress responses and undergo p53-independent apoptosis in response to DNA damage. Curr. Biol. 8, 145-155.
2. Allan GJ, Flint DJ, Darling SM, Geh J, Patel K (2000) Altered expression of insulin-like growth factor-1 and insulin like growth factor binding proteins-2 and 5 in the mouse mutant Hypodactyly (Hd) correlates with sites of apoptotic activity. Anat. Embryol. (Berl.) 202, 1-11.
3. Armstrong L, Lako M, Lincoln J, Cairns PM, Hole N (2000) mTert expression correlates with telomerase activity during the differentiation of murine embryonic stem cells. Mech. Dev. 97 109-116.
4. Artandi SE, DePinho RA (2000) Mice without telomerase: what can they teach us about human cancer? Nat. Med. 6, 852-855.
5. Backman S, Stambolic V, Mak T (2002) PTEN function in mammalian cell size regulation. Curr. Opin. Neurobiol. 12, 516-522.
6. Bargonetti J, Manfredi JJ (2002) Multiple roles of the tumor suppressor p53. Curr. Opin. Oncol. 14, 86-91.
7. Baumann P, Cech TR (2001) Pot1, the putative telomere end-binding protein in fission yeast and humans. Science 292, 1171-1175.
8. Baumann P, Podell E, Cech TR (2002) Human Pot1 (protection of telomeres) protein: cytolocalization, gene structure, and alternative splicing. Mol. Cell Biol. 22, 8079-8087.
9. Bertram MJ, Berube NG, Hang-Swanson X, Ran Q, Leung JK, Bryce S, Spurgers K, Bick RJ, Baldini A, Ning Y, Clark LJ, Parkinson EK, Barrett JC, Smith JR, Pereira-Smith OM (1999) Identification of a gene that reverses the immortal phenotype of a subset of cells and is a member of a novel family of transcription factor-like genes. Mol. Cell Biol. 19, 1479-1485.
10. Bhattacharya B, Miura T, Brandenberger R, Mejido J, Luo Y, Yang AX, Joshi BH, Ginis I, Thies RS, Amit M, Lyons I, Condie BG, Itskovitz-Eldor J, Rao MS, Puri RK (2004) Gene expression in human embryonic stem cell lines: unique molecular signature. Blood 103 2956-2964.
11. Blasco MA, Lee HW, Hande MP, Samper E, Lansdorp PM, DePinho RA, Greider CW (1997) Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 91, 25-34.
12. Blume-Jensen P, Hunter T (2001) Oncogenic kinase signaling. Nature 411, 355-365.
13. Brandenberger R, Khrebtukova I, Thies RS, Miura T, Jingli C, Puri R, Vasicek T, Lebkowski J, Rao M (2004a) MPSS profiling of human embryonic stem cells. BMC Dev. Biol. 4, 10.
14. Brandenberger R, Wei H, Zhang S, Lei S, Murage J, Fisk GJ, Li Y, Xu C, Fang R, Guegler K, Rao MS, Mandalam R, Lebkowski J, Stanton LW (2004b) Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation. Nat. Biotechnol. 22, 707-716.
15. Broccoli D, Smogorzewska A, Chong L, de Lange T (1997) Human telomeres contain two distinct Myb-related proteins, TRF1 and TRF2. Nat. Genet. 17, 231-235.
16. Burdon T, Smith A, Savatier P (2002) signaling, cell cycle and pluripotency in embryonic stem cells. Trends Cell Biol. 12 432-438.
17. Campisi J (2001) Cellular senescence as a tumor-suppressor mechanism. Trends Cell Biol. 11, S27-S31.
18. Chang JT, Chen YL, Yang HT, Chen CY, Cheng AJ (2002) Differential regulation of telomerase activity by six telomerase subunits. Eur. J. Biochem. 269, 3442-3450.
19. Chen Y, Li X, Eswarakumar VP, Seger R, Lonai P (2000) Fibroblast growth factor (FGF) signaling through Pl 3-kinase and Akt/PKB is required for embryoid body differentiation. Oncogene 19, 3750-3756.
20. Cheng JQ, Altomare DA, Klein MA, Lee WC, Kruh GD, Lissy NA, Testa JR (1997) Transforming activity and mitosis-related expression of the AKT2 oncogene: evidence suggesting a link between cell cycle regulation and oncogenesis. Oncogene 14, 2793-2801.
21. Cheng JQ, Ruggeri B, Klein WM, Sonoda G, Altomare DA, Watson DK, Testa JR (1996) Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA. Proc. Natl Acad. Sci. USA 93, 3636-3641.
22. Cole MD, McMahon SB (1999) The Myconcoprotein: a critical evaluation of transactivation and target gene regulation. Oncogene 18, 2916-2924.
23. Colgin LM, Baran K, Baumann P, Cech TR, Reddel RR (2003) Human POT1 facilitates telomere elongation by telomerase. Curr. Biol. 13, 942-946.
24. Cong YS, Wen J, Bacchetti S (1999) The human telomerase catalytic subunit hTERT: organization of the gene and characterization of the promoter. Hum. Mol. Genet. 8, 137-142.
25. Cong YS, Wright WE, Shay JW (2002) Human telomerase and its regulation. Microbiol. Mol Biol. Rev. 66, 407-425.
26. Coqueret O (2002) Linking cyclins to transcriptional control. Gene 299, 35-55.
27. Crackower MA, Oudit GY, Kozieradzki I, Sarao R, Sun H, Sasaki T, Hirsch E, Suzuki A, Shioi T, Irie-Sasaki J, Sah R, Cheng HY, Rybin VO, Lembo G, Fratta L, Oliveira-dos-Santos AJ, Benovic JL, Kahn CR, Izumo S, Steinberg SF, Wymann MP, Backx PH, Penninger JM (2002) Regulation of myocardial contractility and cell size by distinct P13K-PTEN signaling pathways. Cell 110, 737-749.
28. Datta SR, Brunet A, Greenberg ME (1999) Cellular survival: a play in three Akts. Genes Dev. 13, 2905-2927.
29. Davis A, Bradley A (1993) Mutation of N-myc in mice: what does the phenotype tell us? Bioessays 15, 273-275.
30. Davis AC, Wims M, Spotts GD, Hann SR, Bradley A (1993) A null c-myc mutation causes lethality before 10.5 days of gestation in homozygotes and reduced fertility in heterozygous female mice. Genes Dev. 7, 671-682.
31. Di Leonardo A, Linke SP, Clarkin K, Wahl GM (1994) DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts. Genes Dev. 8, 2540-2551.
32. Dimri GP, Itahana K, Acosta M, Campisi J (2000) Regulation of a senescence checkpoint response by the E2F1 transcription factor and p14 (ARF) tumor suppressor. Mol. Cell Biol. 20, 273-285.
33. Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CA Jr, Butel JS, Bradley A (1992) Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356, 215-221.
34. Dyson N (1998) The regulation of E2F by pRB-family proteins. Genes Dev. 12, 2245-2262.
35. Feng J, Funk WD, Wang SS, Weinrich SL, Avilion AA, Chiu CP, Adams RR, Chang E, Allsopp RC, Yu J, Le S, West MD, Harley CB, Andrews WH, Greider CW, Villeponteau B. (1995) The RNA component of human telomerase. Science. 269, 1236-1241.
36. Ferbeyre G, de Stanchina E, Lin AW, Querido E, McCurrach ME, Hannon GJ, Lowe SW (2002) Oncogenic ras and p53 cooperate to induce cellular senescence. Mol. Cell Biol. 22, 3497-3508.
37. Forsyth NR, Wright WE, Shay JW (2002) Telomerase and differentiation in multicellular organisms: turn it off, turn it on, and turn it off again. Differentiation 69, 188-197.
38. Ginis I, Luo Y, Miura T, Thies S, Brandenberger R, Gerecht-Nir S, Amit M, Hoke A, Carpenter MK, Itskovitz-Eldor J, Rao MS (2004) Differences between human and mouse embryonic stem cells. Dev. Biol. 269, 360-380.
39. Greenberg RK, Chuter TA, Lawrence-Brown M, Haulon S, Nolte L (2004) Analysis of renal function after aneurysm repair with a device using suprarenal fixation (Zenith AAA Endovascular Graft) in contrast to open surgical repair. J. Vasc. Surg. 39, 1219-1228.
40. Greenberg RA, O'Hagan RC, Deng H, Xiao Q, Hann SR, Adams RR, Lichtsteiner S, Chin L, Morin GB, DePinho RA (1999) Telomerase reverse transcriptase gene is a direct target of c-Myc but is not functionally equivalent in cellular transformation. Oncogene 18, 1219-1226.
41. Greider CW, Blackburn EH (1987) The telomere terminal transferase of Tetrahymena is a ribonucleoprotein enzyme with two kinds of primer specificity. Cell 51, 887-898.
42. Griffith JD, Comeau L, Rosenfield S, Stansel RM, Bianchi A, Moss H, de Lange T (1999) Mammalian telomeres end in a large duplex loop. Cell 97, 503-514.
43. Halaban R (1999) Melanoma cell autonomous growth: the Rb/E2F pathway. Cancer Metastasis Rev. 18, 333-343.
44. Harley CB (1991) Telomere loss: mitotic clock or genetic time bomb? Mutat. Res. 256, 271-282.
45. Harley CB, Futcher AB, Greider CW (1990) Telomeres shorten during ageing of human fibroblasts. Nature 345, 458-460.
46. Hayflick L (1976) The cell biology of human aging. N. Engl. J. Med. 295, 1302-1308.
47. Hayflick L, Moorhead PS (1961) The serial cultivation of human diploid cell strains. Exp. Cell Res. 25, 585-621.
48. Honda R, Tanaka H, Yasuda H (1997) Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett. 420, 25-27.
49. Horikawa I, Cable PL, Afshari C, Barrett JC (1999) Cloning and characterization of the promoter region of human telomerase reverse transcriptase gene. Cancer Res. 59, 826-830.
50. Huntriss J, Hinkins M, Oliver B, Harris SE, Beazley JC, Rutherford AJ, Gosden RG, Lanzendorf SE, Picton HM (2004) Expression of mRNAs for DNA methyltransferases and methyl-CpG-binding proteins in the human female germ line, preimplantation embryos, and embryonic stem cells. Mol. Reprod. Dev. 67, 323-336.
51. Jacks T, Remington L, Williams BO, Schmitt EM, Halachmi S, Bronson RT, Weinberg RA (1994) Tumor spectrum analysis in p53-mutant mice. Curr. Biol. 4, 1-7.
52. Jirmanova L, Afanassieff M, Gobert-Gosse S, Markossian S, Savatier P (2002) Differential contributions of ERK and P13-kinase to the regulation of cyclin D1 expression and to the control of the G1/S transition in mouse embryonic stem cells. Oncogene 21, 5515-5528.
53. Jones SN, Roe AE, Donehower LA, Bradley A (1995) Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53. Nature 378, 206-208.
54. Kastan MB, Radin AI, Kuerbitz SJ, Onyekwere O, Wolkow CA, Civin CI, Stone KD, Woo T, Ravindranath Y, Craig RW (1991) Levels of p53 protein increase with maturation in human hematopoietic cells. Cancer Res. 51, 4279-4286.
55. Katakura Y, Nakata E, Miura T, Shirahata S (1999) Transforming growth factor beta triggers two independent-senescence programs in cancer cells. Biochem. Biophys. Res. Commun. 255, 110-115.
56. Katakura Y, Nakata E, Tabira Y, Miura T, Teruya K, Tsuchiya T, Shirahata S (2003) Decreased tumorigenicity in vivo when transforming growth factor beta treatment causes cancer cell senescence. Biosci. Biotechnol. Biochem. 67, 815-821.
57. Kenyon C (2001) A conserved regulatory system for aging. Cell 105, 165-168.
58. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL, Shay JW (1994) Specific association of human telomerase activity with immortal cells and cancer. Science 266, 2011-2015.
59. Kiyono T, Foster SA, Koop JI, McDougall JK, Galloway DA, Klingelhutz AJ (1998) Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature 396, 84-88.
60. Klinz F, Bloch W, Addicks K, Hescheler J (1999) Inhibition of phosphatidylinositol-3-kinase blocks development of functional embryonic cardiomyocytes. Exp. Cell Res. 247, 79-83.
61. Kruk PA, Balajee AS, Rao KS, Bohr VA (1996) Telomere reduction and telomerase inactivation during neuronal cell differentiation. Biochem. Biophys. Res. Commun. 224, 487-492.
62. Kurz DJ, Hong Y, Trivier E, Huang HL, Decary S, Zang GH, Luscher TF, Erusalimsky JD (2003) Fibroblast growth factor-2, but not vascular endothelial growth factor, upregulates telomerase activity in human endothelial cells. Arterioscler. Thromb. Vasc. Biol. 23 748-754.
63. Kyo S, Takakura M, Taira T, Kanaya T, Itoh H, Yutsudo M, Ariga H, Inoue M (2000) Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT). Nucleic Acids Res. 28, 669-677.
64. de Lange T (2002) Protection of mammalian telomeres. Oncogene 21, 532-540.
65. Langley E, Pearson M, Faretta M, Bauer UM, Frye RA, Minucci S, Pelicci PG, Kouzarides T (2002) Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence. EMBO J. 21, 2383-2396.
66. Lee SW, Fang L, Igarashi M, Ouchi T, Lu KP, Aaronson SA (2000) Sustained activation of Ras/Raf/mitogen-activated protein kinase cascade by the tumor suppressor p53. Proc. Natl Acad. Sci. USA 97, 8302-8305.
67. Lee JH, Hart SR, Skalnik DG (2004) Histone deacetylase activity is required for embryonic stem cell differentiation. Genesis 38, 32-38.
68. Lin AW, Barradas M, Stone JC, van Aelst L, Serrano M, Lowe SW (1998) Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling. Genes Dev. 12, 3008-3019.
69. Lin SY, Elledge SJ (2003) Multiple tumor suppressor pathways negatively regulate telomerase. Cell 113, 881-889.
70. Lin K, Hsin H, Libina N, Kenyon C (2001) Regulation of the Caenorhabditis elegans longevity protein DAF-16 by insulin/IGF-1 and germline signaling. Nat. Genet. 28, 139-145.
71. Lin TC, Yen JM, Gong KB, Hsu TT, Chen LR (2003) IGF-1/IGFBP-1 increases blastocyst formation and total blastocyst cell number in mouse embryo culture and facilitates the establishment of a stem-cell line. BMC Cell Biol. 4, 14.
72. Loayza D, De Lange T (2003) POT1 as a terminal transducer of TRF1 telomere length control. Nature 423, 1013-1018.
73. Longo VD, Finch CE (2003) Evolutionary medicine: from dwarf model systems to healthy centenarians? Science 299, 1342-1346.
74. Lopatina NG, Poole JC, Saldanha SN, Hansen NJ, Key JS, Pita MA, Andrews LG, Tollefsbol TO (2003) Control mechanisms in the regulation of telomerase reverse transcriptase expression in differentiating human teratocarcinoma cells. Biochem. Biophys. Res. Commun. 306, 650-659.
75. Louis JM, McFarland VW, May P, Mora PT (1988) The phosphoprotein p53 is down-regulated post-transcriptionally during embryogenesis in vertebrates. Biochim. Biophys. Acta 950, 395-402.
76. MacCallum DE, Hupp TR, Midgley CA, Stuart D, Campbell SJ, Harper A, Walsh FS, Wright EG, Balmain A, Lane DP, Hall PA (1996) The p53 response to ionising radiation in adult and developing murine tissues. Oncogene 13, 2575-2587.
77. Maser RS, DePinho RA (2002) Connecting chromosomes, crisis, and cancer. Science 297, 565-569.
78. Miura T, Luo Y, Khrebtukova I, Brandenberger R, Zhou D, Thies RS, Vasicek T, Young H, Lebkowski J, Carpenter MK, Rao MS (2004) Monitoring early differentiation events in human embryonic stem cells by MPSS and EST scan. Stem Cells Dev. in press.
79. Miyauchi H, Minamino T, Tateno K, Kunieda T, Toko H, Komuro I (2004) Akt negatively regulates the in vitro lifespan of human endothelial cells via a p53/p21-dependent pathway. EMBO J. 23 212-220.
80. Montes de Oca Luna R, Wagner DS, Lozano G (1995) Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature 378,203-206.
81. Munoz-Jordan JL, Cross GA, de Lange T, Griffith JD (2001) t-loops at trypanosome telomeres. EMBO J. 20, 579-588.
82. Niida H, Matsumoto T, Satoh H, Shiwa M, Tokutake Y, Furuichi Y, Shinkai Y (1998) Severe growth defect in mouse cells lacking the telomerase RNA component. Nat. Genet. 19, 203-206.
83. O'Connor R, Kauffmann-Zeh A, Liu Y, Lehar S, Evan GI, Baserga R, Blattler WA (1997) Identification of domains of the insulin-like growth factor I receptor that are required for protection from apoptosis. Mol. Cell Biol. 17, 427-435.
84. Oren M, Reich NC, Levine AJ (1982) Regulation of the cellular p53 tumor antigen in teratocarcinoma cells and their differentiated progeny. Mol. Cell Biol. 2, 443-449.
85. Oren M, Rotter V (1999) Introduction: p53 - the first twenty years. Cell Mol. Life Sci. 55, 9-11.
86. Ortega S, Malumbres M, Barbacid M (2002) Cyclin D-dependent kinases, INK4 inhibitors and cancer. Biochim. Biophys. Acta 1602 73-87.
87. Pearson M, Carbone R, Sebastiani C, Cioce M, Fagioli M, Saito S, Higashimoto Y, Appella E, Minucci S, Pandolfi PP, Pelicci PG (2000) PML regulates p53 acetylation and premature senescence induced by oncogenic Ras. Nature 406, 207-210.
88. Prisco M, Romano G, Peruzzi F, Valentinis B, Baserga R (1999) Insulin and IGF-I receptors signaling in protection from apoptosis. Horm. Metab. Res. 31, 80-89.
89. Prost S, Bellamy CO, Clarke AR, Wyllie AH, Harrison DJ (1998) p53-independent DNA repair and cell cycle arrest in embryonic stem cells. FEBS Lett. 425, 499-504.
90. Rosler ES, Fisk GJ, Ares X, Irving J, Miura T, Rao MS, Carpenter MK (2004) Long-term culture of human embryonic stem cells in feeder-free conditions. Dev. Dyn. 229, 259-274.
91. Sato N, Sanjuan IM, Heke M, Uchida M, Naef F, Brivanlou AH (2003) Molecular signature of human embryonic stem cells and its comparison with the mouse. Dev. Biol. 260, 404-413.
92. Savatier P, Huang S, Szekely L, Wiman KG, Samarut J (1994) Contrasting patterns of retinoblastoma protein expression in mouse embryonic stem cells and embryonic fibroblasts. Oncogene 9, 809-818.
93. Savatier P, Lapillonne H, van Grunsven LA, Ruckin BB, Samarut J (1996) Withdrawal of differentiation inhibitory activity/leukemia inhibitory factor up-regulateS D-type cyclins and cyclin-dependent kinase inhibitors in mouse embryonic stem cells. Oncogene 12, 309-322.
94. Schmid P, Lorenz A, Hameister H, Montenarh M (1991) Expression of p53 during mouse embryogenesis. Development 113 857-865.
95. Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW (1997) Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88, 593-602.
96. Sherr CJ (1998) Tumor surveillance via the ARF-p53 pathway. Genes Dev. 12, 2984-2991.
97. Sherr CJ, DePinho RA (2000) Cellular senescence: mitotic clock or culture shock? Cell 102, 407-410.
98. Smith JR, Pereira-Smith OM (1996) Replicative senescence: implications for in vivo aging and tumor suppression. Science 273, 63-67.
99. Smogorzewska A, De Lange T (2004) Regulation of telomerase by telomeric proteins. Annu. Rev. Biochem. 73, 177-208.
100. Smogorzewska A, van Steensel B, Bianchi A, Oelmann S, Schaefer MR, Schnapp G, de Lange T (2000) Control of human telomere length by TRF1 and TRF2. Mol. Cell Biol. 20, 1659-1668.
101. Soddu S, Blandino G, Scardigli R, Coen S, Marchetti A, Rizzo MG, Bossi G, Cimino L, Crescenzi M, Sacchi A (1996) Interference with p53 protein inhibits hematopoietic and muscle differentiation. J. Cell Biol. 134, 193-204.
102. Sperger JM, Chen X, Draper JS, Antosiewicz JE, Chon CH, Jones SB, Brooks JD, Andrews PW, Brown PO, Thomson JA (2003) Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors. Proc. Natl Acad. Sci. USA 100, 13350-13355.
103. Stansel RM, de Lange T, Griffith JD (2001) T-loop assembly in vitro involves binding of TRF2 near the 3′ telomeric overhang. EMBO J. 20, 5532-5540.
104. Staveley BE, Ruel L, Jin J, Stambolic V, Mastronardi FG, Heitzler P, Woodgett JR, Manoukian AS (1998) Genetic analysis of protein kinase B (AKT) in Drosophila. Curr. Biol. 8, 599-602.
105. Stead E, White J, Faast R, Conn S, Goldstone S, Rathjen J, Dhingra U, Rathjen P, Walker D, Dalton S (2002) Pluripotent cell division cycles are driven by ectopic Cdk2, cyclin A/E and E2F activities. Oncogene 21, 8320-8333.
106. van Steensel B, de Lange T (1997) Control of telomere length by the human telomeric protein TRF1. Nature 385, 740-743.
107. van Steensel B, Smogorzewska A, de Lange T (1998) TRF2 protects human telomeres from end-to-end fusions. Cell 92, 401-413.
108. Sulis ML, Parsons R (2003) PTEN: from pathology to biology. Trends Cell Biol. 13, 478-483.
109. Sun H, Lesche R, Li DM, Liliental J, Zhang H, Gao J, Gavrilova N, Mueller B, Liu X, Wu H (1999) PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathway. Proc. Natl Acad. Sci. USA 96, 6199-6204.
110. Szibor M, Holtz J (2003) Mitochondrial ageing. Basic Res. Cardiol. 98, 210-218.
111. Takakura M, Kyo S, Kanaya T, Hirano H, Takeda J, Yutsudo M, Inoue M (1999) Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells. Cancer Res. 59, 551-557.
112. Tang DG, Tokumoto YM, Apperly JA, Lloyd AC, Raff MC (2001) Lack of replicative senescence in cultured rat oligodendrocyte precursor cells. Science 291, 868-871.
113. Testa JR, Bellacosa A (2001) AKT plays a central role in tumorigenesis. Proc. Natl Acad. Sci. USA 98, 10983-10985.
114. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM (1998) Embryonic stem cell lines derived from human blastocysts. Science 282, 1145-1147.
115. Thomson JA, Marshall VS (1998) Primate embryonic stem cells. Curr. Top. Dev Biol. 38, 133-165.
116. Tyner SD, Venkatachalam S, Choi J, Jones S, Ghebranious N, Igelmann H, Lu X, Soron G, Cooper B, Brayton C, Hee Park S, Thompson T, Karsenty G, Bradley A, Donehower LA (2002) p53 mutant mice that display early ageing-associated phenotypes. Nature 415, 45-53.
117. Van Zant G (2003) Genetic control of stem cells: implications for aging. Int. J. Hematol. 77, 29-36.
118. Vanfleteren JR, Braeckman BP (1999) Mechanisms of life span determination in Caenorhabditis elegans. Neurobiol. Aging 20, 487-502.
119. Wadhwa R, Kaul SC, Mitsui Y (1994) Cellular mortality to immortalization: mortalin. Cell Struct. Funct. 19, 1-10.
120. Wolkowicz R, Rotter V (1997) The DNA binding regulatory domain of p53: see the C. Pathol Biol. (Paris) 45, 785-796.
121. Wright WE, Shay JW (2000) Telomere dynamics in cancer progression and prevention: fundamental differences in human and mouse telomere biology. Nat. Med. 6, 849-851.
122. Wu KJ, Grandori C, Amacker M, Simon-Vermot N, Polack A, Lingner J, Dalla-Favera R (1999) Direct activation of TERT transcription by c-MYC. Nat. Genet. 21, 220-224,
123. Xu RH, Chen X, Li DS, Li R, Addicks GC, Glennon C, Zwaka TP, Thomson JA (2002) BMP4 initiates human embryonic stem cell differentiation to trophoblast. Nat. Biotechnol. 20, 1261-1264.
124. Xu C, Inokuma MS, Denham J, Golds K, Kundu P, Gold JD, Carpenter MK (2001) Feeder-free growth of undifferentiated human embryonic stem cells. Nat. Biotechnol. 19, 971-974.
125. Zhang HG, Wang J, Yang X, Hsu HC, Mountz JD (2004) Regulation of apoptosis proteins in cancer cells by ubiquitin. Oncogene 23 2009-2015.